StockData
Benitec Biopharma Inc. logo

Benitec Biopharma Inc. (BNTC) shareholders

BNTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$8.15−0.39 (-4.57%)

Close on Nov 17, 2026Market cap $284.29MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
99.4%
35M of 35M shares
Institutional holders
87
12 new, 10 sold out
Net institutional buying
5M
In Q2 2026
Insider trades, 12 months
12 buys · 0 sales
Net bought $2.44M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Suvretta Capital Management, LLC
Joint filing with Aaron Cowen (44.10%), Averill Master Fund, Ltd. (37.80%) and 1 more
17,761,94544.10%13D (active) amendmentNov 7, 2025
Aaron Cowen
Joint filing with Suvretta Capital Management, LLC (49.90%), Averill Master Fund, Ltd. (44.47%) and 1 more
15,623,65949.90%13D (active) amendmentMar 26, 2025
Franklin Advisers, Inc.
Joint filing with Franklin Resources, Inc. (18.10%)
4,493,69118.10%13G (passive) amendmentDec 31, 2024
Franklin Resources, Inc.
Joint filing with Franklin Advisers, Inc. (10.60%)
3,751,70910.60%13G (passive) amendmentDec 31, 2025
Janus Henderson Group PLC
Joint filing with Janus Henderson Biotech Innovation Master Fund Ltd (6.10%)
3,382,8369.99%13G (passive) amendmentNov 28, 2025
RA Capital Healthcare Fund, L.P.
Joint filing with RA Capital Management, L.P. (5.50%), Peter Kolchinsky (5.50%) and 1 more
1,850,0005.50%13G (passive)Nov 7, 2025
Steven M. Oliveira
Joint filing with Nemean Asset Management, LLC (8.39%)
791,2358.89%13G (passive)Apr 22, 2024
Adage Capital Management, L.P.
Joint filing with Adage Capital Partners, L.P. (9.99%), Adage Capital Partners GP, L.L.C. (9.99%) and 2 more
264,5109.99%13G (passive) amendmentDec 31, 2023

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of BNTCValueChange% of portfolio
Suvretta Capital Management, LLC11,548,35133.11%$154.52M–2.83%
Nantahala Capital Management, LLC2,976,7428.53%$39.83M+1,538,3710.66%
Jupiter Topco LLC2,478,5477.11%$33.11MNew0.01%
Franklin Resources Inc2,412,8886.92%$32.28M+34,7290.01%
Adage Capital Partners Gp, L.L.C.2,120,6726.08%$28.37M–0.04%
Ra Capital Management, L.P.1,850,0005.30%$24.75M–0.22%
BlackRock, Inc.1,407,1384.03%$18.83M+221,3970.00%
Simplify Asset Management Inc.1,005,5572.88%$13.45M+443,3150.19%
Vanguard Capital Management LLC954,5332.74%$12.77M+22,9770.00%
Infinitum Asset Management, LLC923,0062.65%$12.35M–1.26%
Millennium Management LLC921,2992.64%$12.33M+269,2350.00%
Alyeska Investment Group, L.P.750,0002.15%$10.04M–0.03%
Silverarc Capital Management, LLC679,8261.95%$9.10M−37,8990.95%
Balyasny Asset Management L.P.650,5031.86%$8.70M−3,3320.01%
Geode Capital Management, LLC611,7361.75%$8.19M+87,6320.00%
Ameriprise Financial Inc401,2451.15%$5.37M−7,5250.00%
State Street Corp377,9731.08%$5.06M+39,7240.00%
MYDA Advisors LLC250,0000.72%$3.35M+25,0000.50%
Schonfeld Strategic Advisors LLC235,3570.67%$3.15M+82,1780.01%
AWM Investment Company, Inc.187,9770.54%$2.52M–0.22%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 20268735M99.4%12 / 3622 / 106M0M
Q1 20268832M93.1%25 / 3513 / 83M1M
Q4 20257232M90.8%20 / 2715 / 49M1M
Q3 20255623M66.4%6 / 289 / 71M0M
Q2 20255723M65.0%25 / 1312 / 52M1M
Q1 20253722M62.8%10 / 166 / 33M0M
Q4 20243019M54.5%8 / 154 / 36M1M
Q3 20242514M39.3%8 / 58 / 08M0M
Q2 2024186M16.4%6 / 82 / 14M0M
Q1 2024131M3.7%0 / 42 / 00M0M
Q4 2023131M3.4%3 / 31 / 10M0M
Q3 2023111M3.6%11 / 00 / 01M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

90 funds held BNTC in Q2 2026, 57% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of BNTCValue% of fundAs of
Simplify Health Care ETF1,005,5572.88%$13.45M3.75%Jun 30, 2026
Franklin Biotechnology Discovery Fund995,1522.85%$11.65M1.01%Jul 31, 2026
Vanguard Total Stock Market Index Fund649,5421.86%$8.69M0.00%Jun 30, 2026
iShares Russell 2000 ETF533,5041.53%$7.14M0.01%Jun 30, 2026
Franklin Small Cap Growth Fund357,5311.02%$4.19M0.17%Jul 31, 2026
Vanguard Extended Market Index Fund281,8990.81%$3.77M0.00%Jun 30, 2026
Fidelity Small Cap Index Fund233,0340.67%$2.73M0.01%Jul 31, 2026
iShares Russell 2000 Value ETF188,3320.54%$2.52M0.02%Jun 30, 2026
Fidelity Extended Market Index Fund130,9660.38%$1.51M0.00%May 31, 2026
Vanguard Russell 2000 Index Fund99,9690.29%$1.16M0.01%May 31, 2026
iShares Micro-Cap ETF71,5270.21%$957.03K0.06%Jun 30, 2026
Schwab Small-Cap Index Fund51,7450.15%$605.93K0.01%Jul 31, 2026
Fidelity Total Market Index Fund42,2980.12%$488.96K0.00%May 31, 2026
Master Small Cap Index Series41,8530.12%$559.99K0.01%Jun 30, 2026
Fidelity Series Total Market Index Fund38,6250.11%$446.51K0.00%May 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Megan BostonChief Financial Officer, Director25,9270.07%Nov 20, 2025
Jerel A. BanksChief Executive Officer, Director––Nov 20, 2025
Sophie MukadamChief Operating Officer6,0160.02%Nov 20, 2025
J. Kevin BuchiDirector155,7230.45%Jun 30, 2026
David Matthew FriedmanDirector––May 28, 2026
Sharon MatesDirector––Jan 26, 2026
Aaron CowenDirector, 10% owner1,848,1565.30%Dec 29, 2025
Montanova Capital, LlcDirector, 10% owner9,538,17527.34%Dec 29, 2025
Averill Master Fund, Ltd.Director, 10% owner7,920,17522.71%Dec 29, 2025
Kishan MehtaDirector––Dec 3, 2025
Edward F. SmithDirector0–Dec 3, 2025
Peter FrancisDirector5,0380.01%Dec 3, 2025
Averill Madison Master Fund, Ltd.10% owner1,826,6535.24%Dec 29, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
J. Kevin Buchi
Director
Jun 29, 2026Gift−51,813––52,097
Aaron Cowen
Director, 10% owner
Dec 29, 2025Buy+11,587$13.44$155.73K1,848,156
Aaron Cowen
Director, 10% owner
Dec 29, 2025Buy+65,800$13.44$884.35K9,700,195
Aaron Cowen
Director, 10% owner
Dec 26, 2025Buy+2,516$13.10$32.96K1,836,569
Aaron Cowen
Director, 10% owner
Dec 26, 2025Buy+14,320$13.10$187.59K9,634,395
Aaron Cowen
Director, 10% owner
Dec 23, 2025Buy+42,600$12.85$547.41K9,620,075
Aaron Cowen
Director, 10% owner
Dec 23, 2025Buy+7,400$12.85$95.09K1,834,053
Averill Madison Master Fund, Ltd.
10% owner
Dec 22, 2025Buy+2,892$12.08$34.94K1,826,653
Averill Madison Master Fund, Ltd.
10% owner
Dec 22, 2025Buy+16,650$12.08$201.13K9,577,475
Averill Madison Master Fund, Ltd.
10% owner
Dec 19, 2025Buy+13,950$11.48$160.15K9,560,825
Averill Madison Master Fund, Ltd.
10% owner
Dec 19, 2025Buy+2,434$11.48$27.94K1,823,761
Averill Madison Master Fund, Ltd.
10% owner
Dec 18, 2025Buy+1,515$11.24$17.03K1,821,327
Averill Madison Master Fund, Ltd.
10% owner
Dec 18, 2025Buy+8,700$11.24$97.79K9,546,875
Montanova Capital, Llc
Director, 10% owner
Nov 7, 2025Buy+730,370$13.50$9.86M9,538,175
Montanova Capital, Llc
Director, 10% owner
Nov 7, 2025Buy+751,111$13.50$10.14M1,819,812
Montanova Capital, Llc
Director, 10% owner
Mar 31, 2025Buy+1,267$12.63$16.00K1,068,031
Montanova Capital, Llc
Director, 10% owner
Mar 31, 2025Buy+9,503$12.63$120.02K8,802,748
Montanova Capital, Llc
Director, 10% owner
Mar 31, 2025Buy+670$13.22$8.86K1,068,701
Montanova Capital, Llc
Director, 10% owner
Mar 31, 2025Buy+5,057$13.22$66.85K8,807,805
Aaron Cowen
10% owner
Mar 26, 2025Buy+106,200$13.00$1.38M1,066,764
Aaron Cowen
10% owner
Mar 26, 2025Buy+793,800$13.00$10.32M8,793,245
J. Kevin Buchi
Director
Mar 12, 2025Gift+103,626––103,626
J. Kevin Buchi
Director
Mar 12, 2025Gift−103,626––284
J. Kevin Buchi
Director
Feb 27, 2025Option exercise+51,813$3.86$200.00K103,910
Aaron Cowen
10% owner
Dec 24, 2024Buy+17,730$11.25$199.46K7,999,455
Aaron Cowen
10% owner
Dec 24, 2024Buy+2,288$11.25$25.74K960,554
Aaron Cowen
10% owner
Dec 23, 2024Buy+3,142$10.98$34.50K958,266
Aaron Cowen
10% owner
Dec 23, 2024Buy+24,360$10.98$267.47K7,981,725
Montanova Capital, Llc
Director, 10% owner
Dec 3, 2024Buy+37,190$9.60$357.02K7,957,365
Montanova Capital, Llc
Director, 10% owner
Dec 3, 2024Buy+4,810$9.60$46.18K955,124
Averill Master Fund, Ltd.
Director, 10% owner
Nov 20, 2024Buy+24,360$10.22$248.96K7,920,175
Averill Master Fund, Ltd.
Director, 10% owner
Nov 20, 2024Buy+3,076$10.22$31.44K950,314
Averill Master Fund, Ltd.
Director, 10% owner
Nov 19, 2024Buy+12,430$9.73$120.94K7,895,815
Averill Master Fund, Ltd.
Director, 10% owner
Nov 19, 2024Buy+1,570$9.73$15.28K947,238
Averill Master Fund, Ltd.
Director, 10% owner
Sep 26, 2024Option exercise+4,605,000$3.86$17.78M6,663,415
Averill Master Fund, Ltd.
Director, 10% owner
Sep 26, 2024Option exercise+588,236$1.93$1.14M2,058,415
Averill Master Fund, Ltd.
Director, 10% owner
Sep 26, 2024Option exercise+148,210––945,668
Averill Master Fund, Ltd.
Director, 10% owner
Sep 26, 2024Option exercise+576,347$3.86$2.22M797,458
Averill Master Fund, Ltd.
Director, 10% owner
Sep 26, 2024Option exercise+1,219,970––7,883,385
J. Kevin Buchi
Director
Aug 11, 2023Buy+51,813––52,097
Megan Boston
Executive Director
Aug 11, 2023Buy+25,907––25,907
Steven Michael Oliveira
10% owner
Dec 9, 2021Buy+10,553$3.04$32.08K1,000,000
Steven Michael Oliveira
10% owner
Nov 29, 2021Buy+37,947$3.18$120.67K989,447
Steven Michael Oliveira
10% owner
May 3, 2021Buy+40,500$4.25$172.13K951,500
Steven Michael Oliveira
10% owner
Apr 30, 2021Buy+120,000$4.18$501.60K911,000
Steven Michael Oliveira
10% owner
Apr 29, 2021Buy+22,877$5.49$125.59K791,000
Steven Michael Oliveira
10% owner
Apr 28, 2021Buy+100,000$5.45$545.00K768,123

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
35.99%
2M shares short
Days to cover
11.3
At 0M shares a day
Change since last report
+0.1%
From 2M shares
Short volume, 20 days
57.0%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Benitec Biopharma's stock actually held short. Settlement fails (shares not delivered on time) peaked at 49,715 shares on Oct 8, 2026 over the last 90 days.

See a number that looks wrong?